[go: up one dir, main page]

MX2014011459A - Proteinas nutritivas cargadas y metodos. - Google Patents

Proteinas nutritivas cargadas y metodos.

Info

Publication number
MX2014011459A
MX2014011459A MX2014011459A MX2014011459A MX2014011459A MX 2014011459 A MX2014011459 A MX 2014011459A MX 2014011459 A MX2014011459 A MX 2014011459A MX 2014011459 A MX2014011459 A MX 2014011459A MX 2014011459 A MX2014011459 A MX 2014011459A
Authority
MX
Mexico
Prior art keywords
amino acid
proteins
acid residues
nutritive
ratio
Prior art date
Application number
MX2014011459A
Other languages
English (en)
Inventor
David Arthur Berry
Brett Adam Boghigian
Nathaniel W Silver
Geoffrey Von Maltzahn
Rajeev Chillakuru
Michael J Hamill
Original Assignee
Pronutria Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pronutria Inc filed Critical Pronutria Inc
Publication of MX2014011459A publication Critical patent/MX2014011459A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

Se proveen proteínas nutritivas cargadas. En algunas modalidades, las proteínas nutritivas tienen una solubilidad acuosa de por lo menos 12.5 g/l a pH 7. En algunas modalidades las proteínas nutritivas tienen una solubilidad acuosa de por lo menos 50 g/l a pH 7. En algunas modalidades las proteínas nutritivas tienen una solubilidad acuosa de por lo menos 100 g/l a pH 7. En algunas modalidades las proteínas nutritivas comprenden por lo menos uno de un nivel de a) una relación de residuos de aminoácidos de cadena ramificada a residuos de aminoácidos presentes en la proteína nutritiva igual a, o mayor que, la relación de los residuos de aminoácidos de cadena ramificada a residuos de aminoácidos totales presentes en una proteína de referencia; b) una relación de residuos de leucina a residuos de aminoácidos totales presentes en la proteína nutritiva igual que, o mayor que, la relación de residuos de leucina a residuos de aminoácidos totales presentes en una proteína de referencia; y c) una relación de residuos de aminoácidos esenciales a residuos de aminoácidos totales presentes en la proteína nutritiva igual a, o mayor que, la relación de residuos de aminoácidos esenciales a residuos de aminoácidos totales presentes en una proteína de referencia. También se proveen ácidos nucleicos que codifican las proteínas, microorganismos recombinantes que producen las proteínas, métodos para producir las proteínas usando microorganismos recombinantes, composiciones que comprenden las proteínas y métodos para usar las proteínas, entre otros.
MX2014011459A 2012-03-26 2013-03-15 Proteinas nutritivas cargadas y metodos. MX2014011459A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615816P 2012-03-26 2012-03-26
PCT/US2013/032212 WO2013148329A1 (en) 2012-03-26 2013-03-15 Charged nutritive proteins and methods

Publications (1)

Publication Number Publication Date
MX2014011459A true MX2014011459A (es) 2015-02-04

Family

ID=49261079

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014011459A MX2014011459A (es) 2012-03-26 2013-03-15 Proteinas nutritivas cargadas y metodos.

Country Status (13)

Country Link
US (6) US8809259B2 (es)
EP (1) EP2831098A4 (es)
JP (3) JP2015519879A (es)
CN (1) CN104470946A (es)
AU (2) AU2013240183B2 (es)
BR (1) BR112014023869A2 (es)
CA (1) CA2868522A1 (es)
HK (1) HK1206370A1 (es)
IL (1) IL234621A0 (es)
MX (1) MX2014011459A (es)
RU (1) RU2014143029A (es)
SG (2) SG11201405842PA (es)
WO (1) WO2013148329A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011041327A1 (en) * 2009-10-01 2011-04-07 The Board Of Trustees Of The Leland Stanford Junior University Light controlled protein dimerization in cells
CA2868469A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
JP2015518470A (ja) 2012-03-26 2015-07-02 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 栄養タンパク質および方法
US20150126441A1 (en) * 2012-03-26 2015-05-07 Pronutria, Inc. Nutritive Fragments and Proteins with Low or No Phenylalanine and Methods
EP3715365A1 (en) 2012-03-26 2020-09-30 Axcella Health Inc. Nutritive fragments, proteins and methods
WO2013148329A1 (en) * 2012-03-26 2013-10-03 Pronutria, Inc. Charged nutritive proteins and methods
JP2016500250A (ja) * 2012-11-20 2016-01-12 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 改変された分泌タンパク質及び方法
WO2014134225A2 (en) * 2013-02-26 2014-09-04 Pronutria, Inc. Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance
MX2016003944A (es) * 2013-09-25 2016-12-09 Pronutria Biosciences Inc Composiciones y formulaciones para mantener y aumentar la masa muscular, fuerza y rendimiento y metodos de produccion y usos de los mismos.
CN107205409A (zh) 2014-08-21 2017-09-26 完美日公司 包含酪蛋白的组合物及其生产方法
US11518797B2 (en) 2014-11-11 2022-12-06 Clara Foods Co. Methods and compositions for egg white protein production
US10188135B2 (en) * 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
JP7041923B2 (ja) 2016-03-03 2022-03-25 学校法人藤田学園 大豆アレルギーの抗原
EP3425395A4 (en) * 2016-03-03 2020-02-12 Hoyu Co., Ltd. SOYBEAN ALLERGY ANTIGEN
SG11201809790XA (en) * 2016-04-04 2018-12-28 Marpe Holdings Llc Immune system modulation for prophylaxis and treatment of diseases and disorders
CN109922662A (zh) 2016-08-25 2019-06-21 完美日股份有限公司 包含乳蛋白和非动物蛋白的食物产品及其生产方法
CN108208018B (zh) * 2017-12-25 2020-10-16 中国科学院沈阳应用生态研究所 油松针叶精油在杀虫农药中的应用及杀虫农药组合物
CN108753621A (zh) * 2018-05-30 2018-11-06 昆明理工大学 一种基于糖蜜废醪液提高单针藻油脂积累的方法
BR112021014987A2 (pt) * 2019-01-29 2022-01-04 Bond Pet Foods Inc Composições e métodos para a produção de produtos alimentícios com proteína animal recombinante
US20250151756A1 (en) * 2019-01-29 2025-05-15 Bond Pet Foods, Inc. Compositions and methods for producing food products with recombinant animal protein
LT3997118T (lt) 2019-07-11 2025-05-26 Clara Foods Co. Gėrimo kompozicija, apimanti rekombinantinio ovomukoido baltymą
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
BR102020009493A2 (pt) * 2020-05-13 2021-11-23 Bernardo De Leão Rosenmann Composto proteico constituído pela biomassa de um organismo geneticamente modificado expressando proteínas fibrilares associado a outras fontes nutricionais provenientes de resíduos agroindustriais
TW202216111A (zh) * 2020-07-03 2022-05-01 米尼奧大學 香氛釋放機制、方法及其用途
CN112480236B (zh) * 2020-12-16 2022-03-29 熊猫乳品集团股份有限公司 一种生物活性肽lecvepncrskr及其制备方法和应用
MX2021014268A (es) * 2021-11-19 2022-02-16 Univ Mexico Nac Autonoma Proteina optimizada que comprende los aminoacidos esenciales para la nutricion humana.
AR133438A1 (es) * 2023-08-01 2025-10-01 Kws Saat Se & Co Kgaa Método para mejorar las propiedades de gelificación de proteínas alternativas
WO2025111412A1 (en) * 2023-11-22 2025-05-30 The Curators Of The University Of Missouri Small peptides for inhibiting sars-cov-2 spike protein-and lps-induced inflammation and cytokine production
CN119614614A (zh) * 2024-12-18 2025-03-14 中国农业大学 水稻抗倒伏及产量相关蛋白strong1及其编码基因与应用

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870801A (en) * 1968-08-09 1975-03-11 Lever Brothers Ltd Fluid aqueous protein compositions and food products prepared therefrom
JPS585672B2 (ja) 1975-01-16 1983-02-01 フシセイユ カブシキガイシヤ テイフエニルアラニンプラステインノセイゾウホウ
US4342832A (en) 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4687782A (en) 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
US5036052A (en) 1988-06-22 1991-07-30 Morishita Pharmaceutical Co., Ltd. Amino acid nutrient compositions
JP3111237B2 (ja) * 1990-11-14 2000-11-20 大塚製薬株式会社 肝疾患患者用組成物
WO1993023571A1 (en) 1992-05-12 1993-11-25 Fred Hutchinson Cancer Research Center Human cell cycle checkpoint genes
GB9310472D0 (en) 1993-05-20 1993-07-07 Univ Warwick Phenylalanine-free protein and dna coding thereof
DE4442668C2 (de) 1994-11-30 1997-09-18 Milupa Ag Verfahren zur Herstellung einer phenylalaninfreien Säuglings- und Kleinkindernahrung
AU4413096A (en) 1994-12-02 1996-06-19 Indiana University Foundation Phenylalanine free proteins
GB9614700D0 (en) 1996-07-12 1996-09-04 Medical Res Council Over-expression of proteins in E.Coli
US6800726B1 (en) 1996-11-01 2004-10-05 Pioneer Hi-Bred International, Inc. Proteins with increased levels of essential amino acids
US6291245B1 (en) 1998-07-15 2001-09-18 Roche Diagnostics Gmbh Host-vector system
US6630320B1 (en) 2000-05-08 2003-10-07 Devisco Foods International, Inc. Treatment of hypertension in mammals with hydrolyzed whey proteins
US20110131679A2 (en) * 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
US20060159724A1 (en) 2000-08-08 2006-07-20 Bell Stacey J Nutritional supplement for the management of weight
US7214786B2 (en) 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
CN1250722C (zh) 2001-03-30 2006-04-12 味之素株式会社 分泌生产蛋白质的方法
GB0110288D0 (en) 2001-04-26 2001-06-20 Novartis Nutrition Ag Composition and treatment method
US20040266689A1 (en) * 2002-01-16 2004-12-30 Mcmichael John Use of calmodulin to promote bone regeneration
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
AU2002314601A1 (en) 2002-06-19 2004-01-06 Centro De Investigacion En Alimentacion Y Desarrollo, A.C. Production and use of soy protein hydrolysates enriched with branched amino acids
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US7273738B2 (en) 2002-10-01 2007-09-25 Novozymes A/S Family GH-61 polypeptides
US7445807B2 (en) 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
US9288998B2 (en) * 2002-11-06 2016-03-22 Medwell Foods, Inc. Edible nutritive composite
US7736678B2 (en) 2002-12-06 2010-06-15 Sunstar Inc. Method of enhancing blood antioxidant activity ingesting a compound in the form of at least one form selected from amongst juice, powder, granule, tablet and capsule, which contains an effective amount of at least one vegetable selected from the group consisting of broccoli, spinach, parsley, komatsuna (Brassicad rapa L.) and japanese radish leaves, and at least one vegetable selected from amongst lettuce, cabbage and celery
US6814983B2 (en) * 2002-12-10 2004-11-09 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
ES2359562T3 (es) 2002-12-20 2011-05-24 Amgen, Inc. Agentes de unión que inhiben miostatina.
US7288570B2 (en) 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
US6812249B2 (en) 2003-03-04 2004-11-02 Sal Abraham Process for preparing a 3-hydroxy-3-methylbutyrate amino acid salt and method of use
US20060150283A1 (en) 2004-02-13 2006-07-06 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US20110183052A1 (en) 2004-10-07 2011-07-28 Next Proteins, Inc. Protein beverage and method of making the same
WO2006047308A2 (en) * 2004-10-21 2006-05-04 Iowa State University Research Foundation, Inc. Novel vegetable protein fractionization process and compositions
WO2007087601A2 (en) 2006-01-25 2007-08-02 Ceres, Inc. Modulating plant protein levels
CA2614769A1 (en) 2005-03-10 2006-09-21 Verenium Corporation Lyase enzymes, nucleic acids encoding them and methods for making and using them
CN102943085A (zh) 2005-03-15 2013-02-27 维莱尼姆公司 纤维素酶、编码它们的核酸及其制备和应用的方法
WO2006105112A2 (en) 2005-03-29 2006-10-05 Ajinomoto Co., Inc. Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people
EP1916913B1 (de) * 2005-08-23 2010-11-10 Dr. Armand Herberger Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs
AU2006294324B2 (en) 2005-09-21 2012-01-19 Burcon Nutrascience (Mb) Corp. Preparation of canola protein isolate involving isoelectric precipitation
EP1945044B1 (en) 2005-10-26 2009-04-15 Hill's Pet Nutrition Inc. Compositions for increasing lean muscle mass and/or reducing fat gain
CN101282657A (zh) 2005-10-28 2008-10-08 雀巢技术公司 支链氨基酸的使用方法
CN101316582A (zh) 2005-11-30 2008-12-03 雀巢技术公司 治疗肌肉损失的方法
EP1968994B1 (en) 2005-12-06 2013-07-03 Synthetic Genomics, Inc. Synthetic genomes
US20100189865A1 (en) 2006-03-01 2010-07-29 Brian Sweet Post-freezing acidification of frozen dairy products
EP1999256B1 (en) 2006-03-07 2012-03-07 Verenium Corporation Aldolases, nucleic acids encoding them and methods for making and using them
ES2575912T3 (es) 2006-12-21 2016-07-04 Basf Enzymes Llc Amilasas y glucoamilasas, ácidos nucleicos que las codifican y métodos para formarlas y utilizarlas
US20080206430A1 (en) 2007-02-22 2008-08-28 Rafael Avila Compositions consisting of blended vegetarian proteins
US20080268038A1 (en) 2007-04-26 2008-10-30 Wolfe Robert R Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
CA2691691C (en) 2007-06-20 2013-09-24 Seth J. Baum Compositions and methods of treating chronic kidney disease
BRPI0814745A2 (pt) 2007-08-03 2014-10-07 Aminotech As Composição de produto.
EP2036978A1 (en) 2007-09-14 2009-03-18 URSAPHARM Arzneimittel GmbH & Co. KG Recombinant preparation of selected bromelain fractions
WO2009076481A1 (en) 2007-12-10 2009-06-18 Healthspan Solutions, Llc Determination of tissue-specific profile of amino acid requirements form the relationship between the amounts of trnas for individual amino acids and the protein-bound amino acid profile of the tissue
US7790688B2 (en) 2008-01-11 2010-09-07 Healthspan Solutions, Llc Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
US8716249B2 (en) 2008-01-31 2014-05-06 Energy Light Llc Compositions and methods for improving cardiovascular health
JP2011514323A (ja) 2008-02-05 2011-05-06 ヘルススパン ソリューションズ， エルエルシー 高齢者の年齢関連性及び年齢特異的健康状態の管理のための治療的栄養を使用するシステム及び方法
US8029830B2 (en) 2008-04-18 2011-10-04 Nuvocare Health Services Inc. Composition and method for promoting internal health and external appearance
GB0812649D0 (en) 2008-07-10 2008-08-20 Prosidion Ltd Compounds
EP2229822B1 (en) * 2008-08-04 2014-06-18 Cereal Ingredients Inc. Food particle for promoting wellness
US20100055246A1 (en) 2008-08-28 2010-03-04 Dong June Ahn Nutrition delivery capsules for functional foods
ES2621936T3 (es) 2008-10-17 2017-07-05 Nestec S.A. Método para preparar composiciones de proteína de suero de leche
US20100179089A1 (en) 2009-01-13 2010-07-15 Deutz Nicolaas E P Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly
US9481737B2 (en) 2009-03-12 2016-11-01 Industrias Nutrigrains, S.A., De C.V. Hybrid vegetable protein and method for obtaining same
US20120178672A1 (en) 2009-03-18 2012-07-12 Wolfe Robert R Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis
WO2010126353A1 (en) 2009-04-27 2010-11-04 N.V. Nutricia Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
US8604168B2 (en) 2009-06-12 2013-12-10 Wisconsin Alumni Research Foundation Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
ES2659084T3 (es) * 2009-06-30 2018-03-13 Burcon Nutrascience (Mb) Corp. Producción de aislados de proteína de soja solubles en ácido ("S800")
BR112012004420A2 (pt) 2009-09-02 2015-09-01 Team Foods Colombia Sa "composição com alto teor proteico para a indústria alimentícia"
US8815806B2 (en) 2009-10-28 2014-08-26 University Of Manitoba Yellow pea seed protein-derived peptides
WO2011078654A1 (en) 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
CA2786307A1 (en) 2010-01-06 2011-07-14 Cargill, Incorporated High protein cooked product
CN102843920A (zh) 2010-01-29 2012-12-26 N·V·努特里奇亚 适用于管饲的、使上消化道和下消化道病症最小化的液体肠营养组合物
JP2011184314A (ja) * 2010-03-04 2011-09-22 Snow Brand Milk Products Co Ltd 筋肉萎縮防止剤
WO2011119023A1 (en) 2010-03-26 2011-09-29 N.V. Nutricia Low protein infant formula with increased essential amino acids
CA2801208C (en) * 2010-06-28 2016-10-04 Nestec S.A. Hypocaloric, high protein nutritional compositions and methods of using same
CN101886107A (zh) 2010-07-02 2010-11-17 广东海洋大学 一种酶法制备马氏珠母贝高f值寡肽的方法
WO2012005568A1 (en) 2010-07-07 2012-01-12 N.V. Nutricia Nutritional composition for the stimulation of muscle protein synthesis
NZ607274A (en) * 2010-07-18 2015-07-31 Glanbia Nutritionals Ireland Ltd High-protein beverages comprising whey protein
EP2605666B1 (en) * 2010-08-18 2022-02-16 Burcon Nutrascience (MB) Corp. Improved production of protein solutions from soy
WO2013075095A1 (en) 2011-11-18 2013-05-23 The Board Of Trustees Of The University Of Arkansas Use of amino acid supplementation for improved muscle recovery
CA2859663A1 (en) 2011-12-22 2013-06-27 Aveo Pharmaceuticals, Inc. Identification of multigene biomarkers
EP2813224A4 (en) 2012-02-06 2015-06-24 Ajinomoto Kk PROPHYLACTIC OR THERAPEUTIC AGENTS AGAINST IDIOPATHIC INFLAMMABLE MUSCLE DISEASES
US20150232520A1 (en) 2012-03-26 2015-08-20 Pronutria, Inc. Charged Nutritive Fragments, Proteins and Methods
WO2013148329A1 (en) * 2012-03-26 2013-10-03 Pronutria, Inc. Charged nutritive proteins and methods
EP3715365A1 (en) 2012-03-26 2020-09-30 Axcella Health Inc. Nutritive fragments, proteins and methods
CA2868469A1 (en) * 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
EP2841590A4 (en) 2012-04-27 2016-03-23 Pronutria Inc NUCLEIC ACIDS, CELLS, AND METHOD FOR PRODUCING SECRETATED PROTEINS
WO2014134225A2 (en) 2013-02-26 2014-09-04 Pronutria, Inc. Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance
MX2016003944A (es) 2013-09-25 2016-12-09 Pronutria Biosciences Inc Composiciones y formulaciones para mantener y aumentar la masa muscular, fuerza y rendimiento y metodos de produccion y usos de los mismos.

Also Published As

Publication number Publication date
JP2021097700A (ja) 2021-07-01
US8809259B2 (en) 2014-08-19
EP2831098A1 (en) 2015-02-04
US20140212541A1 (en) 2014-07-31
AU2017200234A1 (en) 2017-02-02
SG11201405842PA (en) 2014-10-30
US20200109175A1 (en) 2020-04-09
US20170246244A1 (en) 2017-08-31
US9611298B2 (en) 2017-04-04
JP6853801B2 (ja) 2021-03-31
AU2013240183A1 (en) 2014-10-09
RU2014143029A (ru) 2016-05-20
CN104470946A (zh) 2015-03-25
JP2015519879A (ja) 2015-07-16
IL234621A0 (en) 2014-11-30
US8822412B2 (en) 2014-09-02
SG10201604464SA (en) 2016-07-28
BR112014023869A2 (pt) 2017-07-18
US20240150406A1 (en) 2024-05-09
US20140342978A1 (en) 2014-11-20
JP2018139589A (ja) 2018-09-13
JP7303238B2 (ja) 2023-07-04
US10450350B2 (en) 2019-10-22
CA2868522A1 (en) 2013-10-03
WO2013148329A1 (en) 2013-10-03
AU2017200234B2 (en) 2017-06-08
US20130296231A1 (en) 2013-11-07
EP2831098A4 (en) 2016-12-07
HK1206370A1 (en) 2016-01-08
AU2013240183B2 (en) 2016-10-20

Similar Documents

Publication Publication Date Title
MX2014011459A (es) Proteinas nutritivas cargadas y metodos.
HK1206764A1 (en) Nutritive proteins and methods
HK1206763A1 (en) Charged nutritive fragments, proteins and methods
MX2014011600A (es) Proteínas nutritivas, fragmentos y métodos.
HK1214739A1 (zh) 工程化的分泌蛋白质和方法
PH12013502234A1 (en) Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
MX2014011614A (es) Fragmentos y proteinas nutritivas con fenilalanina baja o nula y metodos.
HK1206761A1 (en) Nutritive fragments, proteins and methods
MY160552A (en) Low protein infant formula with increased essential amino acids
IN2014CN00414A (es)
MX352823B (es) Formulaciones de proteinas que contienen aminoacidos.
PH12020551955A1 (en) Anti-cd63 antibodies, conjugates, and uses thereof
WO2015031726A3 (en) Engineered primate l-methioninase for therapeutic purposes
EA201590611A1 (ru) Новые молекулы, связывающие il-17a, и их медицинское применение
MY180953A (en) Acyl-acp thioesterase
MX354156B (es) Dipeptido que comprende un aminoacido no proteogenico.
AR128395A2 (es) Péptidos novedosos capaces de inducir la formación de anticuerpos contra pcsk9
WO2014194129A3 (en) Cell-free synthetic incorporation of non-natural amino acids into proteins
EA201691011A1 (ru) Последовательность модифицированного эндолизина el188
MY187334A (en) Xylanase
NZ709120A (en) Beta-hexosyl-transferases and uses thereof
WO2015108856A3 (en) Methods for enhancing the delivery of active agents
EA201590431A1 (ru) Пшеница с новыми аллелями rht-b1
NZ738982A (en) Composition comprising amino acid and cyclic dipeptide
PH12012501810A1 (en) Plants having enhanced yield-related traits and method for making the same